UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2
Open Access
- 1 January 2025
- journal article
- Published by Tech Science Press in Oncology Research
- Vol. 33 (9) , 2331-2351
Abstract
Background: U2AF homology motif kinase 1 (UHMK1) has been associated with RNA processing and protein phosphorylation, thereby influencing tumor progression. The study aimed to explore its regulatory mechanisms and biological functions in human prostate cancer (PCa). Methods: In this study, we systematically evaluated the expression and prognostic significance of UHMK1 in public databases, followed by validation through immunohistochemistry (IHC) in PCa specimens. Both gain-of-function and loss-of-function experiments were conducted to elucidate the role of UHMK1 in vitro and in vivo. Additionally, a series of molecular and biochemical assays were performed to investigate the regulatory mechanisms underlying UHMK1 activity. Results: Our findings revealed that UHMK1 expression was significantly upregulated in PCa tissues and correlated with poor patient prognosis, as demonstrated by analysis of public datasets and confirmed by immunohistochemical staining. Functional studies showed that UHMK1 depletion suppressed tumor cell proliferation and metastasis, while its overexpression promoted these processes. Mechanistically, we identified that UHMK1 phosphorylates nuclear receptor coactivator 3 (NCOA3), which subsequently activates activating transcription factor 4 (ATF4) to upregulate methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) transcription. Interestingly, MTHFD2 was found to reciprocally enhance UHMK1 expression, establishing a positive feedback loop. Conclusions: In conclusion, our data suggest that the UHMK1-MTHFD2 axis forms a positive feedback loop that drives PCa progression. Targeting this loop represents a promising therapeutic strategy for restraining prostate cancer development and progression.Keywords
This publication has 58 references indexed in Scilit:
- Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2024;86:148–63European Urology, 2025
- CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progressionCancer Letters, 2024
- Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastomaCancer Letters, 2022
- Activation of translocator protein alleviates mechanical allodynia and bladder dysfunction in cyclophosphamide‐induced cystitis through repression of BDNF‐mediated neuroinflammationEuropean journal of pain, 2022
- Bladder cancer‐associated transcript 1 promotes melanoma cell proliferation and invasion via the miR‐374b‐5p/U2‐associated factor homology motif kinase 1 axisThe Kaohsiung Journal of Medical Sciences, 2021
- Triple-arm androgen blockade for advanced prostate cancer: a reviewMedical Oncology, 2021
- Dual‐Specificity Tyrosine Phosphorylation–Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma ProgressionHepatology, 2019
- Serine, but Not Glycine, Supports One-Carbon Metabolism and Proliferation of Cancer CellsCell Reports, 2014
- Protein phosphatase 2A regulates deoxycytidine kinase activity via Ser‐74 dephosphorylationFEBS Letters, 2014
- Different Requirements of the Kinase and UHM Domains of KIS for Its Nuclear Localization and Binding to Splicing FactorsJournal of Molecular Biology, 2008